United Therapeutics Corporation (UTHR)
Net profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 984,800 | 727,300 | 475,800 | 514,800 | -104,500 |
Revenue | US$ in thousands | 2,268,200 | 1,903,900 | 1,666,900 | 1,483,300 | 1,448,800 |
Net profit margin | 43.42% | 38.20% | 28.54% | 34.71% | -7.21% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $984,800K ÷ $2,268,200K
= 43.42%
United Therapeutics Corp's net profit margin has shown significant variation over the past five years. The company's net profit margin increased from 2019 to 2020, reaching 34.71%, indicating a strong profitability ratio. However, in 2021, there was a drop in the net profit margin to 28.23%, which may suggest a decrease in profitability compared to the previous year.
The most significant improvement in net profit margin was observed in 2022, where it increased to 37.56%, showing a positive trend in the company's profitability. Additionally, in 2023, United Therapeutics Corp achieved a notable net profit margin of 42.31%, indicating an even higher level of profitability compared to the previous years.
Overall, the trend in United Therapeutics Corp's net profit margin demonstrates both fluctuations and improvements over the five-year period, with notable increases in the past two years, highlighting the company's potential for generating profits relative to its revenue.
Peer comparison
Dec 31, 2023